Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
326 DKK | -0.61% | +2.19% | +160.80% |
May. 07 | Gubra A/S Announces Management Changes | CI |
Apr. 17 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
780M | - | - | - | - | - | |
121B | ||||||
107B | ||||||
24.82B | - | |||||
22.48B | - | |||||
18.32B |
- Stock Market
- Equities
- GUBRA Stock
- Charts Gubra A/S
- Sector Chart